We are live on
!
Find out more
ELC
Edgar Lomax Company Portfolio holdings
AUM
$1.4B
1-Year Est. Return
20.67%
This Fund
S&P 500
This Quarter
Est. Return
+9.46%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.67B
AUM Growth
+$112M
(+7.2%)
Cap. Flow
-$16.1M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
40.36%
Holding
62
New
1
Increased
1
Reduced
57
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kyndryl
KD
|
+$1.1M |
| 2 |
iShares S&P 500 Value ETF
IVE
|
+$21.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.78M |
| 2 |
MetLife
MET
|
+$829K |
| 3 |
CVS Health
CVS
|
+$815K |
| 4 |
Cisco
CSCO
|
+$651K |
| 5 |
Chevron
CVX
|
+$630K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.62% |
| 2 | Financials | 17.06% |
| 3 | Technology | 10.32% |
| 4 | Consumer Staples | 9.96% |
| 5 | Industrials | 9.6% |
Similar funds
FCP
TWM
AI
IAS
EA
QC
SCM
SP
Edgar Lomax Company's Q4 2021 Portfolio in Review
As of Q4 2021, Edgar Lomax Company held 62 positions worth $1.67B, up 7.2% from $1.56B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 1.6%. Edgar Lomax Company opened 1 new position and made no exits, leaving the 62-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Financials and Technology.
- Edgar Lomax Company's largest Q4 2021 buy was Kyndryl: 50,967 shares worth $923K.
- Edgar Lomax Company added most to iShares S&P 500 Value ETF in Q4 2021, an estimated $21.1K increase.
- Edgar Lomax Company's biggest Q4 2021 reduction was IBM, cutting an estimated $1.78M.
- Edgar Lomax Company's ten largest holdings make up 40% of its $1.67B portfolio in Q4 2021.
- Edgar Lomax Company opened 1 new position and closed 0 in Q4 2021.
- Edgar Lomax Company's portfolio value rose 7.2% quarter-over-quarter to $1.67B.
Based on Edgar Lomax Company's 13F filing for Q4 2021, filed 11 Feb 2022.